These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14003718)

  • 1. [Mouse protection studies with zymosan vaccines and properdin sera. Contribution to unspecified immunity (resistance)].
    ZIMMERMANN G
    Acta Biol Med Ger; 1962; 9():412-27. PubMed ID: 14003718
    [No Abstract]   [Full Text] [Related]  

  • 2. [THE ROLE OF THE PROPERDIN SYSTEM IN NON-SPECIFIC IMMUNITY].
    HOSHINO A
    Nihon Naika Gakkai Zasshi; 1963 Dec; 52():1023-40. PubMed ID: 14158037
    [No Abstract]   [Full Text] [Related]  

  • 3. The properdin system and immunity. III. The zymosan assay of properdin.
    PILLEMER L; BLUM L; LEPOW IH; WURZ L; TODD EW
    J Exp Med; 1956 Jan; 103(1):1-13. PubMed ID: 13278451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The properdin system and immunity. XI. Studies on the interaction of zymosan with the properdin system.
    BLUM L; PILLEMER L; LEPOW IH
    Z Immun exp ther; 1959; 118():313-28. PubMed ID: 13801695
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantitative studies on the properdin-complement system.
    LEON MA
    J Exp Med; 1956 Mar; 103(3):285-93. PubMed ID: 13295486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The properdin system and immunity. XV. Some biologic effects of the administration of zvmosan and other polvsaccharides to rabbits, and the presence of antibodies to zymosan in human and rabbit serum.
    HINZ CF; WEDGWOOD RJ; PILLEMER L
    J Lab Clin Med; 1961 Feb; 57():185-98. PubMed ID: 13714488
    [No Abstract]   [Full Text] [Related]  

  • 7. [The properdin system and its role in infection and immunity. I. The production of active preparations of zymosan].
    NIKITINA VD; KHOLCHEV NV; ANDREEVA ZM; SOKHINA AM; CHERNOKHVOSTOVA EV; PLETENEVA IL
    Zh Mikrobiol Epidemiol Immunobiol; 1960 Aug; 31():12-9. PubMed ID: 13729079
    [No Abstract]   [Full Text] [Related]  

  • 8. [Bactericidal activity of normal and low-properdin sera and of properdin-zymosan complexes].
    SZEMERE G
    Kiserl Orvostud; 1963 Feb; 15():58-61. PubMed ID: 13979914
    [No Abstract]   [Full Text] [Related]  

  • 9. Elevation of properdin levels in mice following administration of bacterial lipopolysaccharides.
    LANDY M; PILLEMER L
    J Exp Med; 1956 Jun; 103(6):823-33. PubMed ID: 13319594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Properdin system and its role in infection and immunity. II. Determination of biological activities of zymosan].
    ANDREEVA ZM; NIKITINA VD
    Zh Mikrobiol Epidemiol Immunobiol; 1960 Nov; 31():49-53. PubMed ID: 13683406
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fibrinolysis and factors of aspecific immunity. Preliminary note].
    Ferrauto A; Giuffrida G; Terranova R
    Boll Soc Ital Biol Sper; 1965 Dec; 41(24):1488-91. PubMed ID: 5878160
    [No Abstract]   [Full Text] [Related]  

  • 12. The possible role of the properdin system in transplantable cancer; the effect of zymosan on transplantable human carcinoma.
    HERBUT PA; KRAEMER WH
    Cancer Res; 1956 Dec; 16(11):1048-52. PubMed ID: 13383472
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies and considerations on properdin survey with zymosan assay].
    SATO M; FUJIWARA A
    Arerugi; 1963; 12():125-30. PubMed ID: 13986722
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison between properdin titers obtained in the zymosan assay and in the bacterio-phage-neutralization assay. 2. Investigation on pathological sera.
    LAURELL AB; REYN A
    Acta Pathol Microbiol Scand; 1959; 47():419-28. PubMed ID: 14414557
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison between properdin titers obtained in the zymosan assay and in the bacteriophage-neutralization assay. 1. investigation on normal human sera.
    LAURELL AB; REYN A
    Acta Pathol Microbiol Scand; 1959; 47():405-18. PubMed ID: 14414558
    [No Abstract]   [Full Text] [Related]  

  • 16. A factor in rheumatoid arthritic sera interfering in the zymosan assay of properdin.
    LAURELL AB
    Acta Pathol Microbiol Scand; 1959; 45(4):392-400. PubMed ID: 13660839
    [No Abstract]   [Full Text] [Related]  

  • 17. [Interrelations of zymosan, properdin & tumors. III. Behavior of the properdin level in benzopyrene sarcoma-bearing rats treated with zymosan].
    FUMAROLA D; MODICA F
    Tumori; 1959; 45(1):46-53. PubMed ID: 13659609
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of properdin titers in sera of normal subjects and patients with leukemia and lymphoma by zymosan and bacteriophage assavs.
    BALTCH AL; HASSIRDJIAN A; OSBORNE W; BUNN PA
    J Lab Clin Med; 1961 Mar; 57():420-7. PubMed ID: 13686461
    [No Abstract]   [Full Text] [Related]  

  • 19. Adaptation of the zymosan assay of properdin to animal sera.
    KENT JF; TOUSSAINT AJ; HOOK WA
    Proc Soc Exp Biol Med; 1957 Dec; 96(3):676-8. PubMed ID: 13505826
    [No Abstract]   [Full Text] [Related]  

  • 20. [Properdin titer following zymosan vaccination in cattle].
    ZIMMERMANN G; HARM M; SCHUTZLER H
    Acta Biol Med Ger; 1963; 10():426. PubMed ID: 14003717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.